Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T16:11:07.078Z.
Calculation as of: 2026-10-06T16:11:07.078Z.
Quote observation: 2026-10-06T16:10:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$1.46B
EV/FCF Ratio
8.70x
TTM Avg
9.15x
3Y Avg
21.82x
5Y Avg
100.71x
Market Cap
$1.44B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.43B
EV/FCF Ratio
86.64x
TTM Avg
263.63x
3Y Avg
263.63x
5Y Avg
163.80x
Market Cap
$1.49B
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.51B
EV/FCF Ratio
226.43x
TTM Avg
112.41x
3Y Avg
82.68x
5Y Avg
178.05x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.47B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 8.70x | 9.15x | 21.82x | 100.71x |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | 4.64x | 4.64x | 4.64x |
| Certara, Inc. (CERT)vs › | $1.46B | 25.43x | 17.90x | 31.06x | 41.90x |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 86.64x | 263.63x | 263.63x | 163.80x |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.51B | 226.43x | 112.41x | 82.68x | 178.05x |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 72.90x | 54.11x | 63.60x | 65.58x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
